Yimin Wu
Malaria Vaccine Development Branch
National Institute of Allergy and Infectious Diseases
Rockville
Maryland
United States of America
Name/email consistency: high
- Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. Wu, Y., Ellis, R.D., Shaffer, D., Fontes, E., Malkin, E.M., Mahanty, S., Fay, M.P., Narum, D., Rausch, K., Miles, A.P., Aebig, J., Orcutt, A., Muratova, O., Song, G., Lambert, L., Zhu, D., Miura, K., Long, C., Saul, A., Miller, L.H., Durbin, A.P. PLoS. ONE (2008)
- Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Wu, Y., Przysiecki, C., Flanagan, E., Bello-Irizarry, S.N., Ionescu, R., Muratova, O., Dobrescu, G., Lambert, L., Keister, D., Rippeon, Y., Long, C.A., Shi, L., Caulfield, M., Shaw, A., Saul, A., Shiver, J., Miller, L.H. Proc. Natl. Acad. Sci. U.S.A. (2006)









